Impact of Intestinal Bacteria on Levodopa Pharmacokinetics in LCIG Therapy

MLA

Yuki Yamanishi, et al. Impact of Intestinal Bacteria on Levodopa Pharmacokinetics in LCIG Therapy. Feb. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1e6b214c9b6003d9a3912e79142bdb6e&authtype=sso&custid=ns315887.

APA

Yuki Yamanishi, Mohammed Emamussalehin Choudhury, Akira Yoshida, Yuko Hosokawa, Noriyuki Miyaue, Satoshi Tada, Rina Ando, Shinobu Murakami, Hitoshi Miyamoto, & Masahiro Nagai. (2022). Impact of Intestinal Bacteria on Levodopa Pharmacokinetics in LCIG Therapy.

Chicago

Yuki Yamanishi, Mohammed Emamussalehin Choudhury, Akira Yoshida, Yuko Hosokawa, Noriyuki Miyaue, Satoshi Tada, Rina Ando, Shinobu Murakami, Hitoshi Miyamoto, and Masahiro Nagai. 2022. “Impact of Intestinal Bacteria on Levodopa Pharmacokinetics in LCIG Therapy,” February. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1e6b214c9b6003d9a3912e79142bdb6e&authtype=sso&custid=ns315887.